Related references
Note: Only part of the references are listed.Customized oligonucleotide microarray gene expression based classification of neuroblastoma patients outperforms current clinical risk stratification
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome
Matthias Fischer et al.
CLINICAL CANCER RESEARCH (2006)
Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma
R Spitz et al.
CLINICAL CANCER RESEARCH (2006)
Chromosome 1p and 11q deletions and outcome in neuroblastoma
EF Attiyeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Surgical risk factors in primary surgery for localized neuroblastoma:: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group
G Cecchetto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study
T Oue et al.
JOURNAL OF PEDIATRIC SURGERY (2005)
Wait and see strategy in localized neuroblastoma in infants: An option not only for cases detected by mass screening
P Fritsch et al.
PEDIATRIC BLOOD & CANCER (2004)
FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma
R Spitz et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2003)
Neuroblastoma screening at one year of age
FH Schilling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Natural course of neuroblastoma detected by mass screening: A 5-year prospective study at a single institution
H Nishihira et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Neuroblastoma - Current drug therapy recommendations as part of the total treatment approach
F Berthold et al.
DRUGS (2000)
Share Paper
